Purpose: To investigate and classify headaches in adult people with epilepsy, to evaluate the burden of headaches, and to compare findings with a population-based epidemiological study. Methods: Two hundred eighty (61.4% women) people with epilepsy (mean age 37.8 AE 14.5, mean duration of epilepsy 13.2 AE 11.9 years) completed a questionnaire collecting socio-demographic and clinical data, questions clarifying their type of a headache, a Qolie-10 questionnaire and a Headache-Attributed Lost Time (HALT) index. An experienced neurologist also interviewed them. Results: 83.2% of respondents reported some type of headache. From those with inter-ictal headaches (77.9%), 39% reported tension-type headache, 31.7% reported migraine, and 7.8% reported medicationoveruse headache and 16% reported possible persistent headache attributed to traumatic head injury. The impact of headache assessed through the HALT grading showed that 40.4% were grade 1, 9.6% grade 2, 14.7% grade 3 and 35.3% grade 4. Although, the prevalences of different headache types were similar to those in our population-based study, migraine seemed to be more common in males with epilepsy than in general population, and medication-overuse headache was more common in people with epilepsy than in the general population. Conclusions: People with epilepsy experience headaches irrespective of their sex or age. The burden of headaches is very important in patients with epilepsy, since headaches usually cause a moderate or severe burden to their quality of life and suggest a clear clinical need. Clinicians should recognize headache as a common comorbidity of epilepsy, as it may influence antiepileptic drug choice, and may need specific treatment.
Introduction
Epilepsy is defined as a brain disorder characterized by an enduring predisposition to generate epileptic seizures and by the neurobiological, cognitive, psychological, and social consequences of this condition [1] . Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally [2] . One of the most useful methods to measure overall burden of a disease is the Disability-adjusted life years (DALYs); these are higher for epilepsy than for Alzheimer's disease, Parkinson's disease and multiple sclerosis combined [3] . Furthermore, people with epilepsy (PWE) are significantly more likely to report poor Health-related quality of life (HRQOL) compared to those without epilepsy [4] . However, epileptic seizures are not the only way to determine burden of epilepsy; this is more complex and determined not only by physiological dysfunction but also by psychological and social dysfunction.
Various comorbidities worsen quality of life in epilepsy: from psychiatric or cognitive dysfunction to rarer physical disorders, such as asthma or digestive disorders [4] [5] [6] [7] [8] . Headache, especially migraine, is one of the most common comorbidities in epilepsy [9] . The prevalence of migraine among PWE is approximately 24%. Moreover, PWE are 2.4 times more likely to be diagnosed with migraine than are people in the general population [10] . On the other hand, the prevalence of epilepsy among people with migraine varies between 1 and 17%, considerably more than the prevalence of epilepsy in general population [11] . The association between epilepsy and migraine (or other types of headache) is bidirectional: either may precede or follow the other, and they may also appear simultaneously [12] . This may be explained by excessive neocortical cellular excitability, the common pathophysiological mechanisms of migraine and epilepsy. In migraine, the hyper-excitability was believed to relate to cortical spreading depression rather than to the hypersynchronous activity that characterizes seizures [13] . However, since hypo-and hyperexcitation in migraine occur sequentially as rebound phenomena (during a spreading depression), a better description of migraine pathophysiology might be "dys-excitability" rather than hyperexcitability [14] . Nevertheless, cortical spreading depression probably explains the link between epilepsy and migraine [15] .
Epilepsy and headache often co-exist, with headache attacks in epilepsy being temporally related to the occurrence of epileptic seizures, either as pre-ictal, ictal, post-ictal or inter-ictal events [14] . To make things even more difficult, new data suggest that a headache may sometimes be the only ictal manifestation of an epileptic seizure [14, 16] : so-called "ictal epileptic headache". This new entity has recently been cited in the recently defined and published new classification of headache disorders (ICHD-III) [14, 17] . Other authors have suggested the term "Epileptic headache" instead of "Ictal epileptic headache". They also divide "Epileptic headache"-headache with onset, and cessation if isolated, coinciding with an EEG pattern of epileptic seizure-into two variants: (a) "pure" or "isolated", e.g. "Isolated epileptic headache", or (b) headache followed by other epileptic manifestations, thus actually being an epileptic seizure beginning with headache (as an "aura") [18] . "Ictal epileptic headache" is diagnosed when a headache attack is the only clinical feature of epileptiform discharges, and the headache resolves after administrating an intravenous anticonvulsant drug [15] . Recently, other authors have criticized this definition e.g. because of mandatory presence of the criterion D-"Headache resolves immediately (within few minutes) after intravenous antiepileptic drugs"-since any epileptic phenomenon may not respond to a therapy; thus this criterion should be considered only as supportive rather than mandatory for the diagnosis [15, 19] . Although, the epidemiology and clinical-EEG presentation of "ictal epileptic headache" clearly differs between adults and children [14, 20] , this phenomenon has been described in both children and adults [21, 22] .
Headache strongly influences quality of life, in people with epilepsy and those without. For example, according to The World Health Organization report (WHO, 2001) , migraine is ranked 19th among the worldwide causes of disability and responsible for 1.4% of all Years Lived with Disability (YLDs) [23] . Furthermore, headache is very common in the general population: the Eurolight project gave a lifetime prevalence of any headache (unadjusted for sex or age) as 91.3% [24] . Moreover, the general population shows sex-related differences in headache prevalence: women report headache, especially migraine, more often than men [25] [26] [27] . Thus, some questions arise: is the burden of migraine (or other type of headache) the same in both the general population and PWE? Are there sex-related differences in headache prevalence in PWE?
Aims
Our study aimed to: 1) estimate the prevalence of headache and its most common types among the people with epilepsy; 2) evaluate the burden of headaches for people with epilepsy; 3) compare our findings with those of a population-based epidemiological study.
Methods
The cross-sectional study was performed in the Epilepsy Centre of Vilnius University Hospital Santariškiu? klinikos in 2015. Two hundred and eighty-nine Lithuanian-speaking adults with epilepsy and taking treatment with antiepileptic drugs (AED) agreed to complete an anonymous questionnaire which collected their socio-demographic data, asked questions clarifying their type of a headache, and contained a Qolie-10 (Quality of life in epilepsy-10) questionnaire and a Headache-Attributed Lost Time (HALT) index. We compared this information to that recorded in their outpatient cards. An experienced neurologist also conducted faceto-face interviews to clarify the patients' symptoms and disease history. We excluded patients with psychogenic non-epileptic seizures, a single epileptic seizure, or those with evident cognitive decline and dementia. We did not enroll PWE who did not complete or only partly completed the questionnaires and/or were unavailable to attend the interview. We obtained local ethics committee consent for this study.
For socio-demographic data, we collected information about age, sex, education, residence, marital status and financial monthly income. We also asked patients questions about their disease-the cause of epilepsy, seizure type(s), investigation results, details of AEDs and other medications and their frequency of use.
We classified the types of headaches according to the International Headache Disorders Classification, 3rd edition (ICHD-3) published by International Headache Society [17] . Headaches were diagnosed and classified according to completed questionnaires, information in outpatient cards and face-to-face interviews. We made the final decision of each person's headache type after the face-to-face interviews, which, for consistency, were conducted by the same experienced neurology doctor. We classified each person's headache as being only one type of headache, according to predominant symptoms. We did not consider the concept of "Ictal epileptic headache" as we did not record an EEG during headache.
Qolie-10 questionnaire was used to evaluate subjective patient's life quality [28] . The higher the score, the worse the patient's subjective quality of life. HALT (Headache-Attributed Lost Time) index evaluates the burden of the headache and the need for treatment. Based on the HALT index results, we categorised the personal impact (or burden) of a headache to four grades: grade 1-minimal or infrequent impact of a headache, grade 2-mild or infrequent impact, grade 3-moderate impact and grade 4-severe impact. The higher the grade, the greater the need for medical care (grades 3 and 4 indicating the greatest need) [29] .
Before distributing the questionnaire, we reviewed it for simplicity and comprehensibility, and an epilepsy expert evaluated its content. We pilot tested 12 patients to exclude questions that were difficult to comprehend. After completing the questionnaire, the researcher revised any questions about which patients had been unclear.
Descriptive statistics were calculated using Microsoft Office Excel 2007 and SPSS Statistics 20.0 software. Sociodemographic data are presented as proportions (%). Chi-square test and nonparametric Kruskal-Wallis test were performed to compare categorical variables. Mann-Whitney test was performed to analyze categorical and quantitative (with asymmetrical distribution) variables. Correlation between paired samples was calculated using Pearson's correlation coefficient (r), p values < 0.05 were regarded as significant. The HALT index was analyzed descriptively and is presented in percent as proportions.
Results

Study population
Two hundred and eighty out of 289 questionnaires were completed. One hundred and eight (38.6%) men and 172 (61.4%) women aged 18 years and older (mean age was 37.8 AE 14.5 years, 18-84 years) were enrolled into the study. The mean duration of Table 1 The main characteristics of patients with epilepsy with or without headaches. 39 .0% (n = 85, 39.8% of men and 38.5% of women) had tension-type headache; 31.7% (n = 69; 27.7% of men and 34.1% of women) had migraine; 16.0% (n = 35; 19.3% of men and 14.1% of women) had possible persistent headache attributed to traumatic head injury; and 7.8% (n = 17; 8.4% of men and 7.4% of women) had medication-overuse headache. Twelve respondents did not meet the criteria for any of these headache types, and so we did not classify them further, as determining the prevalence of rare types of headaches was not a purpose of this study. The main characteristics of patients (with or without headache) are presented in Table 1 .
There was no statistically significant differences in sex (p > 0.05) or age (p > 0.05) in the prevalence of headache in PWE. The prevalence of headaches in patients with epilepsy compared to population-based findings is presented in Table 2 .
HALT index and Qolie-10
The distribution of PWE who had inter-ictal headache (n = 218) based on HALT index was: 40.4% matched grade 1 of HALT, 9.6%-grade 2, 14.7%-grade 3 and 35.3% were grade 4. Mean HALT index value was 24.6 AE 34.1 and the distribution of grades is shown in Fig. 1 .
The only statistically significant (p = 0.017) relationship between the HALT results and clinical features of epilepsy was the type of epileptic seizure. The average HALT index of patients who had several seizure types (n = 73) was 38.3 AE 45.3 days. The average result of respondents who had only focal seizures (n = 65) was 20.7 AE 30.5 days whereas in people with generalized tonic-clonic seizures (n = 27) it was 19.4 AE 27.4 days. Fig. 2 shows these results.
Neither the duration of disease (p > 0.05), nor the number of drugs used to treat epilepsy (p > 0.05) correlated with HALT results. Only sex correlated significantly with HALT: the mean HALT result for men was 21.6 AE 33.6 days and for women 26.4 AE 34.5 days (p = 0.05). Grade of HA LT index Mean score of HA LT, days Among people with epilepsy and inter-ictal headache, the mean Qolie-10 value was 24.2 AE 7.8 (range 10-47). Qolie-10 scores related to several characteristics of headache: frequency of headache (p < 0.001), type of headache (p < 0.001), and duration of headache (p = 0.006) (Fig. 3) . Moreover, Qolie-10 results correlated moderately with seizure frequency (rho = 0.413, p < 0.001). Those people with more frequent seizures had the highest Qolie-10 scores.
There was a weak statistical correlation (r = 0.398, p < 0.001) between the evaluation quality of life (Qolie-10) and HALT index results among people with epilepsy. Respondents who subjectively evaluated their life quality as being lower were also more likely to have higher HALT index results. The sex of patients had no statistically significant (p < 0.05) impact on the Qolie-10 score.
Discussion
Our study shows that most people with epilepsy experience headaches-83.2% of respondents had some form of headache. There are no previous population studies focused on headache and its prevalence in Lithuanian adults. In order to compare PWE with the general population we therefore used the Eurolight project data, which found that the prevalence of headache among PWE and in the general population is very similar-79.6% of the general population had some type of headache at least once a year [24] . However, in the general population headache is usually more common in women (prevalence 86.0%) than in men (prevalence 71.1%) [24, 25, 27] . However, in our study there were no statistically significant sex-related differences in the prevalence of headache among people with epilepsy (83.7% vs 82.4%).
The most common headache type identified during this study was tension-type headache (39% of respondents); there was no sex-related differences in prevalence. If we compare the prevalence of tension-type headache in this study with that in the general population (mean prevalence 42%), we could suppose that the prevalence of tension-type headache is similar in both the general population and Lithuanian patients with epilepsy [30] . Its prevalence is similar when compared to the average result, but the prevalence of tension-type headache varies greatly between different countries across the world: from 5.1% in Turkey to 74% in Western Europe [31, 32] . Still, there are no sex-related differences of tension-type headache prevalence among PWE, either during this study or among the general population [33] .
The second most common headache among PWE was migraine. Some authors state that the prevalence of migraine among PWE is 2.4 times that of the general population [10] . According to the Eurolight project data, migraine (taking into account only definite migraine and excluding probable migraine) occurs in 22.2% of the population: 14.8% of males and 27.7% of females [24] . Thus the findings in our project are very similar to those in the Eurolight project, except the prevalence of migraine among men is higher in PWE than in the general population [24] .
Also, the prevalence of migraine in the general population differs in studies all over the world: the average prevalence of migraine worldwide is 11.5%, significantly lower than in the Eurolight project. This prevalence figure was estimated in a systemic review, including 19 studies all over the world [34] . Because there have still been no population studies about prevalence of migraine in general Lithuanian adult population, we assumed this average prevalence to be similar to that of migraine in general Lithuanian population. To compare the prevalence in general population to our group of respondents (that is patients with epilepsy) the expected result would show that among our PWE, migraine is 2.1 times more common than in the general population. This may be possibly explained by the similar pathophysiological mechanisms of migraine and epilepsyexcessive neocortical cellular excitability [13] . It is also recognized that channelopathies can cause both epilepsy and/or migraine. Mutations in same genes may cause epilepsy or migraine and sometimes both of these disorders [11, 35, 36] .
Considering that the prevalence of migraine varies so much between different reliable studies, we cannot confidently infer whether the prevalence of migraine among PWE is the same or more than in PWE. Our study found no significant sex-related difference in the prevalence of migraine in PWE, whereas the difference is quite marked among general population: the prevalence of migraine among men is 6-14.8%, whereas among women it is 18-27.7% [24, 26] .
Our study estimated that the prevalence of medication-overuse headache among people with epilepsy is 6.1%, whereas among the general population it varies between 1-2%, and in the Eurolight project was even 3.3% (probable medication-overuse headache) [24, 37, 38] . We might consider why the prevalence of medicationoveruse headache in PWE is so different from that in the general population. A possible explanation is that epilepsy is often followed by many comorbidities, including headache, and most of these conditions are treated with various kinds of analgesic drugs [5] [6] [7] [8] . However, it is worth noting that taking regular analgesic drugs for diseases like inflammatory bowel diseases does not cause medication-overuse headache, unless the person had a headache before starting to take regular analgesic drugs [39] . It seems necessary to have a headache, especially migraine and/or tension-type headache, to develop medication-overuse headache [39, 40] . Moreover, changes in neocortical cellular excitability-the pathophysiological mechanism common to migraine and epilepsy-are probably also important for developing medicationoveruse headache [13, 14, 41] . In addition, there was an interesting distribution of HALT index grades (showing the need for treatment). Though, the prevalence of any type of a headache was similar in the general population and among PWE, there were obvious differences in the burden caused by a headache between those two groups. Among people in the Eurolight project, most respondents (>60%) who reported headache were HALT index grade 1 (0-5 days) and very few respondents were graded 3 or 4 (indicating the likely need of medical care) [24, 29] . However, our results showed that the burden (or personal impact) of a headache for half of PWE was moderate or high, as they were given HALT grade 3 or 4, indicating that they needed intense treatment for headache. Conceivably, the personal impact of a headache on patients with epilepsy was so great because the prevalence of migraine and medication-overuse headache was so high in this population; both of these headache types are cause the greatest burden among the types of headache [42] .
The type of epileptic seizures was the other epilepsy-related factor that was also significantly related to the HALT grading (which show the burden of a headache). Patients with several seizure types were more likely to have higher HALT grading, indicating a higher subjective burden. Conversely, respondents with only one seizure type, whether partial or generalized tonicclonic, more likely had lower HALT grading.
Finally, we used Qolie-10 questionnaire to evaluate the quality of life in PWE [28] . The mean Qolie-10 value was 24 points (range 10-47). Quality of life is subjectively considered to be worse when the Qolie-10 score is higher. It is interesting that Qolie-10 scores did relate to the duration, frequency and type of headache. Respondents with epilepsy who had a longer history of headache, or had more frequent headaches, or who experienced migraine or medication overuse headache, were more likely to judge their life quality in epilepsy as being worse. Moreover, people who evaluated their life quality worse according to Qolie-10 questionnaire tended to have higher HALT index results too.
This study has several limitations. First, there are no population studies focusing on the prevalence of a headache and its types in Lithuania, nor specifically in people with epilepsy; we therefore had to compare our results to studies from other countries, which we expect (but cannot be sure) have similar prevalence to Lithuania. Second, the sample size of our study (n = 280) was too small to assess accurately the rarer types of headaches, such as medication-overuse headache; ideally, we need a larger sample size to determine the prevalence of medication-overuse headache among PWE in Lithuania. Also, each person's headache was classified as being of only one type, according to predominant symptoms: some PWE had several types of headache but we counted only the predominant one. Third, both Qolie-10 questionnaire and HALT index subjectively evaluate life quality in epilepsy or the burden of a headache, and so a person's psycho-emotional state can strongly affect these measures. Epilepsy has many comorbidities: for example, depression and anxiety disorders are diagnosed in 30% of people with epilepsy [6] . We did not assess the prevalence of depression or anxiety disorders in our study, and so cannot ascertain their impact upon our results.
Conclusions
Headache is a very common comorbidity of epilepsy and affects most PWE, irrespective of their sex and age. The most common headache type among PWE is tension-type headache and there is no sex-related difference in the prevalence of migraine. The frequency of a headache, duration of a headache and type of a headache each relate to their quality of life. The burden of a headache is of great importance for PWE. Headache has a moderate or severe impact upon quality of life for half of PWE, suggesting the high need for targeted healthcare. Headache as a comorbidity of epilepsy justifies receiving more clinical attention, since it may influence antiepileptic drug choice, and the headache may need specific treatment.
